Joh Hee-Kyung, Kwon Hyuktae, Son Ki Young, Yun Jae Moon, Cho Su Hwan, Han Kyungdo, Park Jin-Ho, Cho Belong
Department of Medicine, Seoul National University College of Medicine, Seoul, Korea.
Department of Family Medicine, Seoul National University Health Service Center, Seoul, Korea.
Ann Neurol. 2023 Feb;93(2):384-397. doi: 10.1002/ana.26506. Epub 2022 Oct 17.
To examine the associations between the allergic triad (asthma, allergic rhinitis, atopic dermatitis) and risk of dementia.
Participants comprised 6,785,948 adults aged ≥40 years who participated in a national health examination in 2009 without any history of dementia before baseline. From 2009 to 2017, we prospectively investigated the associations between physician-diagnosed allergic diseases and risk of incident dementia (all-cause, Alzheimer's disease [AD], vascular dementia [VaD]) ascertained using national health insurance claims data.
During 8.1 years of follow-up, 260,705 dementia cases (195,739 AD, 32,789 VaD) were identified. Allergic diseases were positively associated with dementia risk. Compared with individuals without allergic diseases, multivariable hazard ratios (HRs) of all-cause dementia were 1.20 (95% confidence interval [CI] 1.19-1.22) in those with asthma, 1.10 (95% CI 1.09-1.12) with allergic rhinitis, 1.16 (95% CI 1.11-1.21) with atopic dermatitis, and 1.13 (95% CI 1.12-1.14) with any of these allergies. Similarly, individuals with any of the allergic triad had a higher risk of AD (HR 1.16, 95% CI 1.14-1.17) and VaD (HR 1.04; 95% CI 1.01-1.06) than those without any allergic disease. As the number of comorbid allergic diseases increased, the risk of dementia increased linearly (P ≤ 0.002). Compared with individuals without allergies, those with all three allergic diseases had substantially increased risk of all-cause dementia (HR 1.54, 95% CI 1.35-1.75), AD (HR 1.46; 95% CI 1.25-1.70), and VaD (HR 1.99, 95% CI 1.44-2.75).
Asthma, allergic rhinitis, and atopic dermatitis were significantly associated with increased risk of all-cause dementia and subtypes, with dose-effect relationships with the severity of allergic diseases. ANN NEUROL 2023;93:384-397.
研究过敏三联征(哮喘、过敏性鼻炎、特应性皮炎)与痴呆风险之间的关联。
研究对象为6785948名年龄≥40岁的成年人,他们于2009年参加了一次全国健康检查,基线时无痴呆病史。从2009年到2017年,我们前瞻性地调查了医生诊断的过敏性疾病与使用国家医疗保险理赔数据确定的新发痴呆症(全因性、阿尔茨海默病[AD]、血管性痴呆[VaD])风险之间的关联。
在8.1年的随访期间,共确定了260705例痴呆病例(195739例AD、32789例VaD)。过敏性疾病与痴呆风险呈正相关。与无过敏性疾病的个体相比,哮喘患者全因性痴呆的多变量风险比(HR)为1.20(95%置信区间[CI]1.19 - 1.22),过敏性鼻炎患者为1.10(95%CI 1.09 - 1.12),特应性皮炎患者为1.16(95%CI 1.11 - 1.21),患有上述任何一种过敏的患者为1.13(95%CI 1.12 - 1.14)。同样,患有过敏三联征中任何一种的个体患AD(HR 1.16,95%CI 1.14 - 1.17)和VaD(HR 1.04;95%CI 1.01 - 1.06)的风险高于无任何过敏性疾病的个体。随着合并过敏性疾病数量的增加,痴呆风险呈线性增加(P≤0.002)。与无过敏的个体相比,患有所有三种过敏性疾病的个体患全因性痴呆(HR 1.54,95%CI 1.35 - 1.75)、AD(HR 1.46;95%CI 1.25 - 1.70)和VaD(HR 1.99,95%CI 1.44 - 2.75)的风险大幅增加。
哮喘、过敏性鼻炎和特应性皮炎与全因性痴呆及其亚型风险增加显著相关,且与过敏性疾病的严重程度存在剂量 - 效应关系。《神经病学纪事》2023年;93:384 - 397。